Skip to main content

Young Caroline's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Dec 3, 2021

Accession no.
0001209191-21-067892
Filed
Dec 3, 2021
Trade date
Nov 1-30, 2021
Filing delay
32 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 21 non-derivative transactions. Open-market purchases total $1.09K. It was filed 32 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Young CarolineCIK 0001684087Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Nov 1, 2021Common StockPPurchaseAcquired+15$2.67+$40.0514,003Direct
Nov 2, 2021Common StockPPurchaseAcquired+15$2.63+$39.4514,018Direct
Nov 3, 2021Common StockPPurchaseAcquired+15$2.71+$40.6514,033Direct
Nov 4, 2021Common StockPPurchaseAcquired+15$2.73+$40.9514,048Direct
Nov 5, 2021Common StockPPurchaseAcquired+15$2.71+$40.6514,063Direct
Nov 8, 2021Common StockPPurchaseAcquired+15$2.95+$44.2514,078Direct
Nov 9, 2021Common StockPPurchaseAcquired+15$3.21+$48.1514,093Direct
Nov 10, 2021Common StockPPurchaseAcquired+15$2.94+$44.114,108Direct
Nov 11, 2021Common StockPPurchaseAcquired+15$2.83+$42.4514,123Direct
Nov 12, 2021Common StockPPurchaseAcquired+15$2.67+$40.0514,138Direct
Nov 15, 2021Common StockPPurchaseAcquired+15$2.71+$40.6514,153Direct
Nov 16, 2021Common StockPPurchaseAcquired+15$2.66+$39.914,168Direct
Nov 17, 2021Common StockPPurchaseAcquired+15$2.58+$38.714,183Direct
Nov 18, 2021Common StockPPurchaseAcquired+15$2.58+$38.714,198Direct
Nov 19, 2021Common StockPPurchaseAcquired+15$2.55+$38.2514,213Direct
Nov 22, 2021Common StockPPurchaseAcquired+15$2.35+$35.2514,228Direct
Nov 23, 2021Common StockPPurchaseAcquired+15$2.29+$34.3514,243Direct
Nov 24, 2021Common StockPPurchaseAcquired+35$2.31+$80.8514,278Direct
Nov 26, 2021Common StockPPurchaseAcquired+35$2.26+$79.114,313Direct
Nov 29, 2021Common StockPPurchaseAcquired+35$2.23+$78.0514,348Direct
Nov 30, 2021Common StockPPurchaseAcquired+35$4.61+$161.3514,383Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)